Actinium Pharmaceuticals, Inc.
ATNMNYSECIK 1388320HealthcareFiscal year ends Dec 31
Reports and events: 213 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1611:42 ET | DEF 14A | Proxy statementPeriod 2026-11-25 | 0001213900-26-110022 |
| 2026-10-1521:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-109884 |
| 2026-08-1421:00 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-090232 |
| 2026-08-0721:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-086769 |
| 2026-06-1821:00 ET | 8-K | 8.01 Other events | 0001213900-26-070193 |
| 2026-05-2921:10 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-062935 |
| 2026-05-0821:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-053980 |
| 2026-03-3021:39 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-036504 |
| 2026-03-2621:00 ET | 8-K/A | 5.07 Shareholder vote results | 0001213900-26-034807 |
| 2026-02-1322:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-016559 |
| 2025-11-2622:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001213900-25-115586 |
| 2025-11-1421:50 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-110979 |
| 2025-11-0522:02 ET | DEF 14A | Proxy statementPeriod 2025-11-26 | 0001213900-25-106706 |
| 2025-08-0821:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-073743 |
| 2025-05-0921:27 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-041614 |
| 2025-05-0921:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-041582 |
| 2025-03-3121:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-026371 |
| 2024-11-2721:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001213900-24-103498 |
| 2024-11-1421:57 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-098534 |
| 2024-11-0522:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-094622 |
| 2024-11-0522:00 ET | DEF 14A | Proxy statementPeriod 2024-11-27 | 0001213900-24-094619 |
| 2024-08-0521:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-065239 |
| 2024-08-0511:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-064993 |
| 2024-04-2621:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-036699 |
| 2024-03-2920:58 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-028038 |
| 2023-12-0122:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001213900-23-092089 |
| 2023-11-0922:05 ET | DEF 14A | Proxy statementPeriod 2023-11-30 | 0001213900-23-085303 |
| 2023-11-0213:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-082459 |
| 2023-08-1421:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-067199 |
| 2023-05-1521:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001213900-23-039902 |
| 2023-03-3121:01 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001213900-23-025597 |
| 2023-03-1022:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001213900-23-019289 |
| 2023-02-2112:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-013059 |
| 2022-12-3022:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-22-084094 |
| 2022-12-0913:00 ET | 8-K | 8.01 Other events | 0001213900-22-078586 |
| 2022-11-2122:01 ET | DEF 14A | Proxy statementPeriod 2022-12-08 | 0001213900-22-074269 |
| 2022-11-1422:01 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001213900-22-072371 |
| 2022-10-3111:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-067378 |
| 2022-08-1221:01 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001213900-22-047496 |
| 2022-06-2912:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-22-035693 |
| 2022-05-1321:01 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001213900-22-026538 |
| 2022-04-1312:00 ET | 8-K | 1.01 Entry into a material agreement | 0001213900-22-019512 |
| 2022-03-2521:00 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001213900-22-015208 |
| 2021-11-1222:15 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001213900-21-058783 |
| 2021-11-0922:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-21-057769 |
| 2021-10-1821:18 ET | DEF 14A | Proxy statementPeriod 2021-11-09 | 0001213900-21-053318 |
| 2021-09-2313:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-049470 |
| 2021-07-3021:01 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-039595 |
| 2021-05-1421:00 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001213900-21-026493 |
| 2021-03-3121:00 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001213900-21-019297 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.